USPTO trademark

VEPJUZYRN

AllowedUSPTOWord markClass 5

"VEPJUZYRN" is a word mark owned by Eli Lilly and Company, filed at the USPTO on December 10, 2025. It has been allowed and covers class 5 (Pharmaceuticals).

View Eli Lilly and Company portfolioGet this data via the API
Official USPTO record
VEPJUZYRN trademark as filed
As filed with the USPTO
Status
Allowed
Since April 14, 2026
Filed
December 10, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99540797
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns VEPJUZYRN

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Eli Lilly and Company

LLY · Indianapolis, United States

8,043 trademarks in the portfolioView company

Representative

Tiffany Trunko

Eli Lilly and Company

Goods and services

What the mark covers

The products and services VEPJUZYRN is filed for, grouped by Nice class.

  • Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Covid-19 disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, weight management, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, peripheral arterial disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Sou teas extension received
  2. Teas change of correspondence received
  3. Attorney/dom.rep.revoked and/or appointed
  4. Teas revoke/app/change addr of atty/dom rep received
  5. Noa e-mailed - sou required from applicant
  6. Official gazette publication confirmation e-mailed
  7. Published for opposition
  8. Notification of notice of publication e-mailed
  9. Approved for pub - principal register
  10. Assigned to examiner

3 earlier steps on the official record.

FAQ

About VEPJUZYRN

Who owns the trademark "VEPJUZYRN"?

The USPTO trademark "VEPJUZYRN" (application 99540797) is owned by Eli Lilly and Company.

What is the status of "VEPJUZYRN"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull VEPJUZYRN and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2b71-d48d-7349-9ba0-3727b38b09da
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b71-d48d-7349-9ba0-3727b38b09da",
  "object": "trademark",
  "mark_text": "VEPJUZYRN",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99540797",
  "filing_date": "2025-12-10",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Eli Lilly and Company",
      "entity_id": "ent_019eb749-c2e4-7669-8d85-00996fda299e"
    }
  ]
}